Bayer Aktiengesellschaft (FRA:BAYN)
Germany
· Delayed Price · Currency is EUR 24.74
+0.01 (0.04%)
At close: May 30, 2025, 10:00 PM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 13.74B EUR in the quarter ending March 31, 2025, a decrease of -0.20%. This brings the company's revenue in the last twelve months to 46.58B, down -0.92% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.58B
Revenue Growth
-0.92%
P/S Ratio
0.52
Revenue / Employee
512.50K
Employees
90,587
Market Cap
24.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 107.35B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Energy AG | 37.44B |
| Siemens Healthineers AG | 23.14B |
Bayer Aktiengesellschaft News
- 2 days ago - Bayer says new lung cancer therapy granted FDA priority review - Seeking Alpha
- 7 days ago - Bayer wins EU recommendation for label expansion of Regeneron-partnered Eylea - Seeking Alpha
- 7 days ago - European markets hold steady as traders await fresh cues; Bayer, Philips, SAP on the move - Seeking Alpha
- 7 days ago - Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals - Reuters
- 8 days ago - Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development - Business Wire
- 8 days ago - Bayer A.G.'s eye disease treatment gets approval in China - Seeking Alpha
- 8 days ago - Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - Benzinga
- 9 days ago - Bayer Highlights New Data from Oncology and Women's Health Portfolios at 2025 ASCO Annual Meeting - Business Wire